Julie Seal, MBA
Julie Seal is a program and portfolio management leader with a track record of advancing complex biopharmaceutical programs from early development through commercialization. She brings deep experience across biologics and small molecules, leading cross-functional efforts spanning nonclinical, translational, clinical, CMC, regulatory, and commercial functions.
As Senior Director of Program Management at Juvena Therapeutics, she leads strategy and execution for JUV-161, driving integrated development planning and cross-functional alignment across key milestones.
Previously, Julie held program leadership roles at Juvena, Corcept Therapeutics, Connect Biopharma, and Myovant Sciences, contributing to development programs, global regulatory strategy, and product launches, including alliance work with large pharma partners. She began her career in commercial strategy and product leadership at Genentech and Gilead.
Julie holds an MBA from Pepperdine University and a B.S. in Biochemical Pharmacology from SUNY Buffalo.
Learn more about Julie